PowerShares S&P SmallCap Health Care ETF

Most Recent

  • uploads///neog pm
    Earnings Report

    Neogen’s Revenue and Income Rose in Fiscal 2Q16

    After Neogen’s (NEOG) fiscal 2Q16 earnings report, NEOG rose by 3.9% to close at $60.24 per share in yesterday’s trade.

    By Gabriel Kane
  • uploads///cmn npm
    Earnings Report

    How Does Cantel Medical Compare to Its Peers?

    Cantel Medical outperformed its peers based on the net profit margin, current ratio, PE ratio, and PBV ratio. It outperformed its ETFs based on the PBV ratio.

    By Gabriel Kane
  • uploads///cmn pm
    Earnings Report

    Cantel Medical’s Revenue and Income Rose in 4Q15

    Cantel Medical reported net revenue of $151.255 million in 4Q15—a rise of 6.88% compared to the net revenue of $141.508 million in 3Q15.

    By Gabriel Kane
  • uploads///neog pe
    Earnings Report

    How Does Neogen Compare to Its Peers?

    The PBV ratios of Neogen (NEOG), Illumina, Bio-Rad Laboratories (ILMN), and VWR International (VWR) are 6.1x, 14.0x, 1.7x, and 2.7x, respectively.

    By Gabriel Kane
  • uploads///cmn pm
    Earnings Report

    Cantel Medical’s Revenue and Income Rise in Fiscal 1Q16

    Cantel Medical (CMN) has a market cap of $2.8 billion. Its YTD (year-to-date) price has been rising quarter-over-quarter in calendar 2015.

    By Gabriel Kane
  • uploads///neog pm
    Earnings Report

    Analyzing Neogen’s Performance in 1Q16

    Neogen (NEOG) has a market cap of $1.84 billion. The company’s YTD (year-to-date) price movement was stable until the last three months of 2015.

    By Gabriel Kane
    • CONNECT with Market Realist
    • Link to Facebook
    • Link to Twitter
    • Link to Instagram
    • Link to Email Subscribe
    Market Realist Logo
    Do Not Sell My Personal Information

    © Copyright 2021 Market Realist. Market Realist is a registered trademark. All Rights Reserved. People may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.